Snowball logo
logo
0605

CTCBIO Inc

060590 KQ
3,060.000.00  (0%)
Estimate
Beta
0.042
Growth
Revenue, YoY
1%
Net income, YoY
451.04%
FCF, YoY
158.75%
About the company
Ticker
060590
ISIN
KR7060590007
Country
Other
Sector (GICS)
Healthcare
CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.

Frequently asked questions

What sector does CTCBIO Inc (060590) operate in?

CTCBIO Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is CTCBIO Inc (060590) current stock price?

As of the latest data, CTCBIO Inc stock price is ₩3,060, with a previous close of ₩3,060.

What is CTCBIO Inc (060590) current market capitalization?

CTCBIO Inc market cap is approximately 73.16 billion.

Does CTCBIO Inc (060590) pay dividends?

No. CTCBIO Inc does not pay a dividend.

What is CTCBIO Inc (060590) beta (volatility) score?

CTCBIO Inc has a beta of 0.042, indicating lower volatility than the overall market.